Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 407 - Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group
Patents for C07D 407 - Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group (11,963)
08/2010
08/17/2010CA2397734C Water soluble prodrugs of azole compounds
08/17/2010CA2370412C Pharmaceutical compounds
08/12/2010US20100204492 process for the extraction of bioactive lignans with high yield and purity from sesame oil
08/12/2010CA2751578A1 Process for the synthesis of cleistanthin
08/11/2010EP1150676B1 Acyl derivatives of 4-demethylpenclomedine, use thereof and preparation thereof
08/11/2010CN1950350B Liquid crystal compound comprising two condensed and substituted rings
08/11/2010CN1712399B Production and use for taxol and muramic acyl dipeptide conjugate substance of immune reinforcer
08/10/2010US7772407 (1S)-1,5-anhydro-1-[3-(1-benzothien-2-ylmethyl)phenyl-D-glucitol and derivatives are Na+-glucose cotransporter inhibitors and are used to treat diabetes and related diseases such as insulin-resistance and obesity
08/10/2010US7772230 chroman compound, the method of its preparation and pharmaceutical applications. The compound are represented by formula (I) and its pharmaceutical salt, where in :x is for O or S; n is for 2, 3 or 4; R1 is 6-situ or 7-situ halogen, C1-4alkyl, C1-4alkyoxyl, benzyloxy, acylamino; R2 is nitrogen-containin
08/05/2010WO2010086366A1 4-aryl-butane-1,3-diamides
08/05/2010WO2010040843A3 Dibenzocycloheptanone derivatives and pharmaceutical agents containing said compounds
08/05/2010US20100197917 Coumarin derivatives useful as tnf alpha inhibitors
08/05/2010US20100197684 Substituted heterocyclic compounds
08/05/2010US20100197569 Cross-linked glycopeptide-cephalosporin antibiotics
08/04/2010EP2212300A1 4-benz0yl-1-substituted-piperazin-2-0ne derivatives as p2x7 modulators
08/04/2010EP2212286A1 Synthesis of quaternary salt compounds
08/04/2010EP1429750B1 Inhibition by 3-deoxyflavonoids of t-lymphocyte activation and therapies related thereto
08/04/2010CN1918141B Aminodibenzodioxin derivative and organic electroluminescent device using same
08/04/2010CN101795701A Inhibitors of acetyl-COA carboxylase for treatment of neuronal hypometabolism
08/04/2010CN101792434A Preparation method of tetra-acylated puerarin
08/03/2010US7767667 Pesticidal heterocycles
08/03/2010US7767249 Preparation of nanoparticles
08/03/2010CA2526228C Quinoline derivatives as phosphodiesterase inhibitors
07/2010
07/29/2010WO2009158467A3 Di-substituted phenyl compounds as phosphodiesterase 10 inhibitors
07/28/2010EP2210876A1 Heterocyclic compound
07/28/2010EP2209504A2 Derivatized tertiary amines and uses thereof
07/28/2010CN1788000B Phthalazinone derivatives
07/28/2010CN101790527A benzothiophene inhibitors of rho kinase
07/27/2010US7763741 Separation of ginkgolides and bilobalide from G. biloba
07/22/2010WO2010081755A1 Novel herbicides
07/22/2010WO2009137339A3 Therapeutic n-aryl or n-heteroaryl pyrazolidine and pyrazolidinone derivatives
07/22/2010CA2749615A1 Novel herbicides
07/21/2010EP1960390B1 Biaryl compounds useful as agonists of the gpr38 receptor
07/21/2010EP1893573B1 Inhibitors of hcv replication
07/21/2010CN1751031B HIV replication inhibiting pyrimidines
07/21/2010CN101784515A Pyridinecarboxamide and benzamide derivatives as taar1 ligands
07/21/2010CN101781292A E-ring substituted silybin derivative and preparation method and medical application thereof
07/21/2010CN101407493B Organic material and use thereof in organic EL device
07/15/2010WO2010080537A1 Gpr120 receptor agonists and uses thereof
07/15/2010WO2009098051A8 Aryl sulfonamides as effective analgesics
07/15/2010US20100179217 Therapeutic compounds
07/15/2010US20100179191 Glucopyranosyl-substituted cyclopropylbenzene derivatives, pharmaceutical compositions containing such compounds, their use as sglt inhibitors and process for their manufacture
07/15/2010CA2746762A1 Gpr120 receptor agonists and uses thereof
07/14/2010EP2206702A1 Bicyclic compound, production and use thereof
07/14/2010EP2205086A2 Fungicidal heterocyclic amines
07/14/2010EP2021333B1 Anti-proliferative compounds deriving from a 3-aryl-coumarine or 3-aryl-quinolin-2-one and uses thereof
07/14/2010CN1823063B Quinoline derivatives as phosphodiesterase inhibitors
07/14/2010CN101778838A Azacyclylbenzamide derivatives as histamine-3 antagonists
07/13/2010US7754823 coating formulations and polymers that utilize a dioxanone containing composition or fatty acid derivative
07/13/2010US7754719 Substituted piperidine derivatives as somatostatin SST1 receptor antagonists
07/13/2010US7754718 To treat viral infections and tumors; hepadnaviruses, flaviviruses, herpesviruses and human immunodeficiency virus; treating 3TC (L(-)SddC) resistant hepatitis B virus infections; 9-benzo[1,3]dioxol-5-yl-8-benzyloxymethyl-naphtho[1,2-d][1,3]dioxole-7-carboxylic acid benzyl ester
07/13/2010CA2432211C Dihydronaphthalene derivative compounds and agent comprising the derivative as active ingredient
07/08/2010WO2010077992A1 Aminopyridine and carboxypyridine compounds as phosphodiesterase 10 inhibitors
07/08/2010WO2010077976A2 Prokineticin receptor antagonists and uses thereof
07/08/2010WO2010076879A1 Sulfated c-glycoside, method for isolating same and method for synthesizing same
07/08/2010US20100174076 Coumarin derivatives useful as tnf alpha inhibitors
07/08/2010US20100173946 Benzimidazolylidene propane-1,3-dione derivative or salt thereof
07/08/2010CA2748729A1 Sulfated c-glycoside, method for isolating same and method for synthesizing same
07/08/2010CA2746307A1 Aminopyridine and carboxypyridine compounds as phosphodiesterase 10 inhibitors
07/07/2010EP2204367A1 Griseofulvin analogues for the treatment of cancer by inhibition of centrosomal clustering
07/07/2010EP2203429A1 Pyridazinone derivatives and use thereof as p2x7 receptor inhibitors
07/07/2010EP2099790B1 Process for preparing nebivolol
07/06/2010CA2454863C Novel pyrroles having hypolipidemic hypocholesteremic activities, process for their preparation and pharmaceutical compositions containing them and their use in medicine
07/06/2010CA2427429C Acylaminoalkyl-substituted benzenesulfonamide derivatives,their preparation, their use and pharmaceutical preparations comprising them
07/06/2010CA2248242C Malononitrile-derivative anion salts, and their uses as ionic conducting materials
07/01/2010WO2010075270A1 4, 6-disubstituted 2-amino-pyrimidines as histamine h4 receptor modulators
07/01/2010WO2010073235A1 Ppar agonist compositions and methods of use
07/01/2010WO2010072770A2 Griseofulvin analogues for the treatment of cancer by inhibition of centrosomal clustering
07/01/2010WO2010027594A3 Cinnamic acid-based oligomers and uses thereof
07/01/2010US20100168226 Spirocyclic tetronic acid derivatives
07/01/2010US20100168169 Substituted 1,3-dioxanes useful as ppar modulators
07/01/2010CA2748124A1 Ppar agonist compositions and methods of use
06/2010
06/30/2010EP2202293A2 New mutactimycin and aldgamycin active compounds and the use thereof in therapy
06/30/2010EP2200989A1 Isoquinolinyl and isoindolinyl derivatives as histamine-3 antagonists
06/30/2010EP1682552B1 Tocopherol-modified therapeutic drug compounds
06/30/2010CN101759689A Preparation method of mangiferin
06/30/2010CN101759688A Method for preparing vitexin rhamnoside
06/30/2010CN101759687A Method for preparing Silymarin
06/29/2010US7745460 LFA1 related immune and/or inflammatory disorders; interactions with leukointegrins; such as fused nitrogen heterocyclic secondary amine derivatives
06/29/2010US7745198 producing the 12-membered ring macrolide compound 11107D having an antitumor activity by biological transformation using genus Mortierella, the genus Streptomyces or the family Micromonosporaceae
06/24/2010WO2010070032A1 Cyclic pyrimidin-4-carboxamides as ccr2 receptor antagonists for treatment of inflammation, asthma and copd
06/24/2010WO2010069877A1 Isothiazole and pyrazole derivatives for use as plant growth regulators
06/24/2010US20100160626 Process For The Preparation Of 3,7-Dihydroxy-1,5-Diazacyclooctanes
06/24/2010CA2747677A1 Cyclic pyrimidin-4-carboxamides as ccr2 receptor antagonists for treatment of inflammation, asthma and copd
06/23/2010EP2197875A1 Diacylglycerol acyltransferase inhibitors
06/23/2010EP1511734B1 Compounds, compositions, and methods
06/23/2010CN1906155B Novel hydroxamic acid ester derivant and pharmaceutical use thereof
06/23/2010CN101754960A Tetrahydropyranochromene gamma secretase inhibitors
06/23/2010CN101215283B Secalonic acid A compound and its preparing method and application in preparing neuron cell protection medicament
06/22/2010US7741456 Polyketides and antibiotics produced by combinatorial techniques
06/17/2010WO2010068720A2 Podophyllotoxin inhibitors of topoisomerase ii
06/17/2010WO2010068663A1 4-azetidinyl-1-heteroaryl-cyclohexanol antagonists of ccr2
06/17/2010WO2010067067A1 Compounds for treating cancer
06/17/2010WO2010067036A1 Novel aryl c-xyloside compounds, and cosmetic use
06/17/2010US20100152176 Modulators of Muscarinic Receptors
06/17/2010US20100152125 Compositions And Methods For The Diagnosis, Treatment, And Prevention Of Amyotrophic Lateral Sclerosis And Related Neurological Diseases
06/17/2010CA2747185A1 Compounds for treating cancer
06/17/2010CA2745969A1 4-azetidinyl-1-heteroaryl-cyclohexanol antagonists of ccr2
06/16/2010EP2196462A1 Polymerizable compound, lactone-containing compound, method for manufacturing lactone-containing compound and polymer compound obtained by polymerizing the polymerizable compound
06/16/2010EP1914229B1 Novel cercosporamide derivative
1 ... 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 ... 120